ACC Genomics

ACC Genomics

The aim of ACC Genomics is to sequence a significantly higher number of genes than now, without increasing the costs – reimbursements from the Italian National Health Service (SSN). An outcome that can be achieved by implementing Next Generation Sequencing (NGS) for diagnostics, for which the IRCCS Members have received funding (2016-2017) of over 5 million euro.

The ACC Genomics working group was set up to carry out this task and to foster collaboration among member organizations in the field of precision medicine (PM) in order to coordinate efforts, avoid overlapping and provide an implementation group.  The approach is bottom-up: the group of experts, harmonised by the scientific coordinator, discuss, together with the ACC working groups, the most suitable genomic methods, depending on the kind of pathology, and report to the Board for funding and implementation.

Following the recent cooperation in health research – rare diseases (Research Consortium IRDiRC), genome consortium (Cancer Genome, ICGC) and epigenome consortium (IHEC) – ACC Genomics was prompted into setting up a flexible framework for cooperation among the IRCCS in the field of Precision Medicine research. The member organizations, while maintaining their own regulations and research funding procedures, benefit from sharing information and know-how.